loader
Please Wait
Applying Filters...

Athena Athena

X

Approved Marketing Authorisations (MA) containing Busulfan in Europe. Original Data : EMA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Aspen Pharma Trading Limited, (1)

02 Fresenius Kabi Oncology Plc (1)

03 PIERRE FABRE MEDICAMENT (1)

04 Pierre Fabre Medicament (1)

05 Pierre Fabre Medicament Production (1)

06 The Fresenius Kabi Oncology Plc (1)

filter

01 Busulfan (3)

02 busulfan (3)

filter

01 Busulfano 60Mg 8 Joined The Parenteral Use (1)

02 CONCENTRATE FOR SOLUTION FOR INFUSION (2)

03 Concentrate to the infusion fluid, resolution (2)

04 FILMDRAGERAD TABLETT (1)

filter

01 Italy (1)

02 Norway (2)

03 Sweden (3)

filter

01 Busilvex (3)

02 Busulfan Fresenius Kabi (2)

03 Myleran (1)

URL Supplier Web Content
FILMDRAGERAD TABLETT
2 MG
Myleran
Sweden
URL Supplier Web Content
CONCENTRATE FOR SOLUTION FOR INFUSION
6 MG / ML
Busulfan Fresenius Kabi
Sweden
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Concentrate to the infusion fluid, resolution
6 mg/ml
Busulfan Fresenius Kabi
Hood glass
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CONCENTRATE FOR SOLUTION FOR INFUSION
6 MG / ML
Busilvex
Sweden
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Busulfano 60Mg 8 Joined The Parenteral Use
8 VIALS EV 10 ml 6 mg/ml
Busilvex
Italy
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Concentrate to the infusion fluid, resolution
6 mg/ml
Busilvex
Hood glass
Norway
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY